Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone loss associated with anorexia nervosa.

Isabelle Legroux-Gerot1, Jean Vignau, Francis Collier

  • 1Service de Rhumatologie, CHRU Lille, Hôpital Roger Salengro, 59037 Lille cedex, France. i-legroux@chru-lille.fr

Joint Bone Spine
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Diabetes & metabolism·2026
Same author

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry.

JBMR plus·2026
Same author

The impact of DXA findings on general practitioners' decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis-data from French General Practice (the IMOGENE study).

Archives of osteoporosis·2026
Same author

Bone Health Following Lifestyle-Induced Weight Loss in Individuals With Overweight/Obesity: A Narrative Review.

Obesity (Silver Spring, Md.)·2025
Same author

Author Correction: Parathyroid hormone receptor agonists in the management of osteoporosis.

Nature reviews. Rheumatology·2025
Same author

METHOFRACT, a methotrexate osteopathy multicentre cohort study.

RMD open·2025

Anorexia nervosa causes significant bone loss, primarily due to inadequate bone formation, not just estrogen deficiency. Effective treatments may involve bone formation enhancers and addressing nutritional factors.

Area of Science:

  • Endocrinology
  • Osteoporosis Research
  • Nutritional Science

Background:

  • Anorexia nervosa (AN) is linked to severe bone loss, with osteoporosis affecting 38-50% of patients.
  • Early onset and prolonged duration of AN exacerbate bone density reduction.

Purpose of the Study:

  • To comprehensively review the epidemiology, diagnosis, pathophysiology, and treatment of bone loss in anorexia nervosa.
  • To elucidate the mechanisms underlying bone loss in AN, differentiating it from postmenopausal osteoporosis.

Main Methods:

  • Literature review focusing on epidemiological data, diagnostic tools (dual-energy X-ray absorptiometry, bone markers), and therapeutic interventions for AN-related bone loss.
  • Analysis of studies investigating the multifactorial causes of bone loss, including hormonal and nutritional influences.

Related Experiment Videos

Main Results:

  • Bone loss in AN is characterized by reduced bone formation rather than increased resorption, implicating nutritional factors and the growth hormone-somatomedin C axis (GH/IGF-I).
  • Estrogen therapy has shown limited benefits; weight restoration and resumption of menses are necessary but insufficient.
  • Insulin-like Growth Factor-I (IGF-I) and combined therapies show promise in enhancing bone formation.

Conclusions:

  • Bone loss in AN is complex and multifactorial, with impaired bone formation being a key feature.
  • Optimal treatment strategies are still debated, but therapies enhancing bone formation, potentially combined with estrogen therapy, warrant further investigation.
  • Addressing nutritional deficits and hormonal imbalances is crucial for managing bone density in AN patients.